Clinical Trial: Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07823595) titled 'Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age' on Sept. 11.

Brief Summary: This clinical study is designed to test how well a medicine called abrocitinib works and how safe it is for young children (ages 2 to under 6) who have moderate-to-severe eczema (also known as atopic dermatitis).Eczema is a skin condition that can cause the skin to be dry, itchy, have scaly patches, blisters and skin infections.

How the study works:

* Children will be randomly placed into two groups:

* 2 out of 3 will get the real medicine (abrocitinib).

* 1 out of 3 will get a placebo (a look-alike liquid with no a...